Home    >   COVID-19 Inhibitors

RVX-208

BET bromodomain antagonist
Catalog No. B17-905B


For enquiry on all COVID-19 Inhibitors email us at orders@signalchem.com


Catalog No. Pack Size Price (USD)
B17-905B-05 5 mg $75
B17-905B-25 25 mg $275
B17-905B-BULK BULK Contact Us  


Overview:

**COVID-19 RELATION**
RVX-208 also knows as Apabetalone is a potent selective inhibitor of the BET bromodomains. The compound has been thoroughly studied for its role against some key viruses such as HIV-1. By interacting with key bromodomain proteins BRD2 and BRD4, RVX-208 may inhibit the interaction of these proteins with the SARS-CoV-2 protein E, aiding in stopping some key viral processes such as cell entry and replication.**

RVX-208 is a potent BET bromodomain antagonist with IC50 of 0.510 µM for BD2, with approximately 170-fold selectivity over BD1 (1,2). Increases apolipoprotein A-1 and HDL cholesterol in vitro and in vivo (3). Reduces atherosclerosis (4).

References:


1. S Picaud et al. Proc. Natl. Acad. Sci. USA 2013 110: 19754

2. KG McLure et al. PLoS One 2013 8:e83190

3. D Bailey et al. J. Am. Coll. Cardiol. 2010 55:2580

4. R Jahagirdar et al. Atherosclerosis 2014 236:91


CAS Registry Number:

1044870-39-4


Molecular Formula:

C20H22N2O5


Appearance:

White powder


Molecular Weight:

370.4


Purity:

>98% (TLC); NMR (conforms)


Solubility:

May be dissolved in DMSO (75 mg/ml); or ethanol (4 mg/ml)


Aliases:

2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-4(3H)-quinazolinone


Storage and Stability:

Store desiccated as supplied at -20°C for up to 2 years. Store solutions at -20°C for up to 1 month.


Molecular Structure:



Product Datasheets



There are no related publications available for this product.


SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox